Vespa velutina chromosome 13, iVesVel2.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU525135.1.\nAssembly name: iVesVel2.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/08/14. The original whole-genome shotgun project has the\naccession CAJVVP000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa velutina Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X5
COORDINATES: polyA evidence [ECO:0006239]
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X1
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X3
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X2
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X7
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X4
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like, transcript variant X6
15-hydroxyprostaglandin dehydrogenase [NAD(+)]-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124953801, transcript variant X4
uncharacterized LOC124953801, transcript variant X5
uncharacterized LOC124953801, transcript variant X3
uncharacterized LOC124953801, transcript variant X6
uncharacterized LOC124953801, transcript variant X2
uncharacterized LOC124953801, transcript variant X8
uncharacterized LOC124953801, transcript variant X7
uncharacterized LOC124953801, transcript variant X1
uncharacterized LOC124953801, transcript variant X9
uncharacterized LOC124953801, transcript variant X10
uncharacterized LOC124953801, transcript variant X11
uncharacterized protein LOC124953801 isoform X5
uncharacterized protein LOC124953801 isoform X6
uncharacterized protein LOC124953801 isoform X4
uncharacterized protein LOC124953801 isoform X2
uncharacterized protein LOC124953801 isoform X3
uncharacterized protein LOC124953801 isoform X1
uncharacterized protein LOC124953801 isoform X7
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase I
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitochondrial genome maintenance exonuclease 1-like
40S ribosomal protein S12, mitochondrial, transcript variant X2
40S ribosomal protein S12, mitochondrial, transcript variant X3
40S ribosomal protein S12, mitochondrial, transcript variant X1
40S ribosomal protein S12, mitochondrial
zinc finger protein 511, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 511, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger protein 511, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger protein 511, transcript variant X4
zinc finger protein 511, transcript variant X3
transcription factor VBP, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcription factor VBP, transcript variant X1
protein DDI1 homolog 2, transcript variant X1
protein DDI1 homolog 2, transcript variant X2
protein LSM14 homolog A, transcript variant X2
protein LSM14 homolog A, transcript variant X1
protein LSM14 homolog A, transcript variant X3
cytochrome c1, heme protein, mitochondrial, transcript variant X2
cytochrome c1, heme protein, mitochondrial isoform X2
cytochrome c1, heme protein, mitochondrial, transcript variant X1
cytochrome c1, heme protein, mitochondrial isoform X1
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X2
ubiquitin-conjugating enzyme E2 variant 2, transcript variant X1
ubiquitin-conjugating enzyme E2 variant 2
tyrosine-protein kinase Src64B, transcript variant X1
tyrosine-protein kinase Src64B, transcript variant X3
tyrosine-protein kinase Src64B, transcript variant X2
tyrosine-protein kinase Src64B isoform X1
tyrosine-protein kinase Src64B isoform X2
uncharacterized LOC124953702, transcript variant X2
uncharacterized LOC124953702, transcript variant X1
uncharacterized LOC124953702, transcript variant X3
uncharacterized protein C20orf85 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
U3 small nucleolar RNA-associated protein 4 homolog
protein lifeguard 1-like, transcript variant X2
protein lifeguard 1-like, transcript variant X1
protein lifeguard 1-like, transcript variant X3
ras-related protein Rab-10, transcript variant X2
ras-related protein Rab-10, transcript variant X1
uridine-cytidine kinase-like 1, transcript variant X1
uridine-cytidine kinase-like 1, transcript variant X2
uridine-cytidine kinase-like 1 isoform X1
uridine-cytidine kinase-like 1 isoform X2
probable Na(+)/H(+) antiporter nhx-9, transcript variant X3
probable Na(+)/H(+) antiporter nhx-9, transcript variant X1
probable Na(+)/H(+) antiporter nhx-9, transcript variant X2
probable Na(+)/H(+) antiporter nhx-9, transcript variant X5
probable Na(+)/H(+) antiporter nhx-9 isoform X3
probable Na(+)/H(+) antiporter nhx-9 isoform X1
probable Na(+)/H(+) antiporter nhx-9 isoform X5
probable Na(+)/H(+) antiporter nhx-9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable Na(+)/H(+) antiporter nhx-9 isoform X4
cell adhesion molecule 3-like, transcript variant X2
cell adhesion molecule 3-like, transcript variant X1
cell adhesion molecule 3-like isoform X1
cell adhesion molecule 3-like isoform X2
choline transporter-like protein 1, transcript variant X3
choline transporter-like protein 1, transcript variant X4
choline transporter-like protein 1, transcript variant X2
choline transporter-like protein 1, transcript variant X1
choline transporter-like protein 1 isoform X1
choline transporter-like protein 1 isoform X2
choline transporter-like protein 1 isoform X3
SNF-related serine/threonine-protein kinase, transcript variant X6
SNF-related serine/threonine-protein kinase, transcript variant X5
SNF-related serine/threonine-protein kinase, transcript variant X3
SNF-related serine/threonine-protein kinase, transcript variant X4
SNF-related serine/threonine-protein kinase, transcript variant X1
SNF-related serine/threonine-protein kinase, transcript variant X2
maternal embryonic leucine zipper kinase isoform X4
serine/threonine-protein kinase DDB_G0283821 isoform X2
SNF-related serine/threonine-protein kinase isoform X3
SNF-related serine/threonine-protein kinase isoform X5
serine/threonine-protein kinase ATG1 isoform X1
Y+L amino acid transporter 2, transcript variant X1
Y+L amino acid transporter 2, transcript variant X3
Y+L amino acid transporter 2, transcript variant X2
DNA topoisomerase 2-binding protein 1-A, transcript variant X2
DNA topoisomerase 2-binding protein 1-A, transcript variant X1
DNA topoisomerase 2-binding protein 1-A, transcript variant X3
DNA topoisomerase 2-binding protein 1-A isoform X2
DNA topoisomerase 2-binding protein 1-A isoform X1
DNA topoisomerase 2-binding protein 1-A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC124953864
protein phosphatase Slingshot, transcript variant X1
protein phosphatase Slingshot, transcript variant X2
protein phosphatase Slingshot, transcript variant X3
protein phosphatase Slingshot, transcript variant X4
protein phosphatase Slingshot, transcript variant X7
protein phosphatase Slingshot, transcript variant X5
protein phosphatase Slingshot, transcript variant X6
serine-rich adhesin for platelets isoform X2
serine-rich adhesin for platelets isoform X1
serine-rich adhesin for platelets isoform X3
protein phosphatase Slingshot isoform X4
protein phosphatase Slingshot isoform X7
serine-rich adhesin for platelets isoform X5
serine-rich adhesin for platelets isoform X6
uncharacterized LOC124953794, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC124953794, transcript variant X2
corrinoid adenosyltransferase-like, transcript variant X2
corrinoid adenosyltransferase-like, transcript variant X1
protein lap1-like, transcript variant X2
protein lap1-like, transcript variant X3
protein lap1-like, transcript variant X5
protein lap1-like, transcript variant X4
protein lap1-like, transcript variant X1
leucine-rich repeat-containing protein 28-like isoform X1
ubiquitin-associated protein 1, transcript variant X1
ubiquitin-associated protein 1, transcript variant X2
leucine-rich repeat-containing protein 28-like isoform X3
ubiquitin-associated protein 1 isoform X2
uncharacterized protein LOC124953790 isoform X1
probable ATP-dependent RNA helicase DDX47, transcript variant X2
probable ATP-dependent RNA helicase DDX47, transcript variant X1
probable ATP-dependent RNA helicase DDX47
CCR4-NOT transcription complex subunit 3
nonsense-mediated mRNA decay factor SMG7-like, transcript variant X1
nonsense-mediated mRNA decay factor SMG7-like, transcript variant X4
nonsense-mediated mRNA decay factor SMG7-like, transcript variant X6
nonsense-mediated mRNA decay factor SMG7-like, transcript variant X5
nonsense-mediated mRNA decay factor SMG7-like, transcript variant X3
nonsense-mediated mRNA decay factor SMG7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
nonsense-mediated mRNA decay factor SMG7-like isoform X3
nonsense-mediated mRNA decay factor SMG7-like isoform X5
nonsense-mediated mRNA decay factor SMG7-like isoform X4
nonsense-mediated mRNA decay factor SMG7-like isoform X2
nonsense-mediated mRNA decay factor SMG7-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclic AMP-dependent transcription factor ATF-6 alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclic AMP-dependent transcription factor ATF-6 alpha, transcript variant X1
cyclic AMP-dependent transcription factor ATF-6 alpha isoform X2
cyclic AMP-dependent transcription factor ATF-6 alpha isoform X1
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X13
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X8
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X11
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X9
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X5
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X4
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X7
TP53-regulated inhibitor of apoptosis 1-like, transcript variant X3
TP53-regulated inhibitor of apoptosis 1-like isoform X2
TP53-regulated inhibitor of apoptosis 1-like isoform X1
TP53-regulated inhibitor of apoptosis 1-like isoform X3
TP53-regulated inhibitor of apoptosis 1-like isoform X4
protein abnormal spindle, transcript variant X2
protein abnormal spindle, transcript variant X1
ubiquitin-like-conjugating enzyme ATG3, transcript variant X2
ubiquitin-like-conjugating enzyme ATG3, transcript variant X1
zinc finger protein 271-like, transcript variant X1
zinc finger protein 271-like, transcript variant X3
zinc finger protein 271-like, transcript variant X2
zinc finger and SCAN domain-containing protein 2-like isoform X1
thioredoxin reductase-like selenoprotein T homolog CG3887
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X1
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X2
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X3
ATP synthase mitochondrial F1 complex assembly factor 2, transcript variant X4
protein eyes shut-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein eyes shut-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein eyes shut-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein eyes shut-like, transcript variant X8
protein eyes shut-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein eyes shut-like, transcript variant X6
protein eyes shut-like, transcript variant X4
protein eyes shut-like, transcript variant X1
protein eyes shut-like, transcript variant X2
ATP synthase mitochondrial F1 complex assembly factor 2
SET domain-containing protein SmydA-8-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger CCCH domain-containing protein 13-like, transcript variant X3
zinc finger CCCH domain-containing protein 13-like, transcript variant X2
zinc finger CCCH domain-containing protein 13-like, transcript variant X4
zinc finger CCCH domain-containing protein 13-like, transcript variant X1
zinc finger CCCH domain-containing protein 13-like isoform X2
zinc finger CCCH domain-containing protein 13-like isoform X1
protein phosphatase 1 regulatory subunit 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 7-like, transcript variant X2
protein phosphatase 1 regulatory subunit 7-like isoform X1
protein phosphatase 1 regulatory subunit 7-like isoform X2
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
D-glucuronyl C5-epimerase B, transcript variant X5
D-glucuronyl C5-epimerase B, transcript variant X4
D-glucuronyl C5-epimerase B, transcript variant X3
D-glucuronyl C5-epimerase B, transcript variant X1
D-glucuronyl C5-epimerase B, transcript variant X2
mitochondrial import inner membrane translocase subunit Tim22, transcript variant X2
mitochondrial import inner membrane translocase subunit Tim22, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim22
serine protease inhibitor 88Ea-like, transcript variant X1
serine protease inhibitor 88Ea-like, transcript variant X2
serine protease inhibitor 88Ea-like isoform X1
serine protease inhibitor 88Ea-like isoform X2
thiamine transporter 2-like, transcript variant X1
thiamine transporter 2-like, transcript variant X3
thiamine transporter 2-like, transcript variant X2
transmembrane protein 43 homolog, transcript variant X1
transmembrane protein 43 homolog isoform X1
transmembrane protein 43 homolog, transcript variant X2
transmembrane protein 43 homolog isoform X2
low density lipoprotein receptor adapter protein 1-like, transcript variant X8
low density lipoprotein receptor adapter protein 1-like isoform X2
low density lipoprotein receptor adapter protein 1-like, transcript variant X4
low density lipoprotein receptor adapter protein 1-like, transcript variant X5
low density lipoprotein receptor adapter protein 1-like, transcript variant X1
low density lipoprotein receptor adapter protein 1-like, transcript variant X3
low density lipoprotein receptor adapter protein 1-like, transcript variant X2
low density lipoprotein receptor adapter protein 1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
low density lipoprotein receptor adapter protein 1-like, transcript variant X6
low density lipoprotein receptor adapter protein 1-like isoform X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like, transcript variant X2
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like isoform X1
beta-1,4-N-acetylgalactosaminyltransferase bre-4-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
nuclear cap-binding protein subunit 3-like
sphingomyelin phosphodiesterase 4, transcript variant X1
sphingomyelin phosphodiesterase 4, transcript variant X2
sphingomyelin phosphodiesterase 4, transcript variant X3
sphingomyelin phosphodiesterase 4, transcript variant X4
sphingomyelin phosphodiesterase 4, transcript variant X5
sphingomyelin phosphodiesterase 4, transcript variant X6
sphingomyelin phosphodiesterase 4 isoform X1
sphingomyelin phosphodiesterase 4 isoform X2
sphingomyelin phosphodiesterase 4 isoform X3
sphingomyelin phosphodiesterase 4 isoform X4
adenosine receptor A2b-like, transcript variant X1
adenosine receptor A2b-like, transcript variant X4
adenosine receptor A2b-like, transcript variant X3
adenosine receptor A2b-like, transcript variant X2
adenosine receptor A2b-like, transcript variant X5
adenosine receptor A2b-like, transcript variant X6
5-hydroxytryptamine receptor 1D-like isoform X1
5-hydroxytryptamine receptor 1D-like isoform X2
beta-2 adrenergic receptor-like isoform X6
probable DNA replication complex GINS protein PSF2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable DNA replication complex GINS protein PSF2, transcript variant X1
probable DNA replication complex GINS protein PSF2, transcript variant X2
probable DNA replication complex GINS protein PSF2 isoform X3
probable DNA replication complex GINS protein PSF2 isoform X2
probable DNA replication complex GINS protein PSF2 isoform X1
TNF receptor-associated factor 4, transcript variant X4
TNF receptor-associated factor 4, transcript variant X3
TNF receptor-associated factor 4, transcript variant X1
TNF receptor-associated factor 4, transcript variant X2
TNF receptor-associated factor 4 isoform X1
TNF receptor-associated factor 4 isoform X2
TNF receptor-associated factor 4 isoform X3
RUS family member 1, transcript variant X1
RUS family member 1, transcript variant X3
RUS family member 1, transcript variant X4
RUS family member 1, transcript variant X2
RUS family member 1, transcript variant X5
RWD domain-containing protein 4, transcript variant X3
RWD domain-containing protein 4, transcript variant X5
RWD domain-containing protein 4, transcript variant X2
RWD domain-containing protein 4, transcript variant X4
RWD domain-containing protein 4, transcript variant X1
kelch domain-containing protein 10 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kelch domain-containing protein 10 homolog, transcript variant X1
kelch domain-containing protein 10 homolog
TRPL translocation defect protein 14, transcript variant X8
TRPL translocation defect protein 14, transcript variant X1
TRPL translocation defect protein 14, transcript variant X2
TRPL translocation defect protein 14, transcript variant X3
TRPL translocation defect protein 14, transcript variant X5
TRPL translocation defect protein 14, transcript variant X4
TRPL translocation defect protein 14, transcript variant X6
TRPL translocation defect protein 14 isoform X8
TRPL translocation defect protein 14 isoform X1
TRPL translocation defect protein 14 isoform X3
TRPL translocation defect protein 14 isoform X2
TRPL translocation defect protein 14 isoform X4
TRPL translocation defect protein 14 isoform X6
TRPL translocation defect protein 14 isoform X5
TRPL translocation defect protein 14, transcript variant X7
TRPL translocation defect protein 14 isoform X7
DNA repair protein RAD51 homolog 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA repair protein RAD51 homolog 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DNA repair protein RAD51 homolog 4-like, transcript variant X1
DNA repair protein RAD51 homolog 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00291
protein real-time, transcript variant X1
protein real-time, transcript variant X2
PHD finger-like domain-containing protein 5A
eukaryotic translation initiation factor 4H-like, transcript variant X1
eukaryotic translation initiation factor 4H-like, transcript variant X2
eukaryotic translation initiation factor 4H-like isoform X2
eukaryotic translation initiation factor 4H-like isoform X1
glycine cleavage system H protein, transcript variant X2
glycine cleavage system H protein, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nuclear hormone receptor FTZ-F1-like
probable medium-chain specific acyl-CoA dehydrogenase, mitochondrial
protein painting of fourth, transcript variant X1
protein painting of fourth, transcript variant X2
zinc finger protein 615, transcript variant X4
zinc finger protein 615, transcript variant X1
zinc finger protein 615, transcript variant X3
zinc finger protein 615, transcript variant X5
zinc finger protein 615, transcript variant X6
zinc finger protein 615, transcript variant X2
palmitoyltransferase app-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
palmitoyltransferase app-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
palmitoyltransferase app-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
palmitoyltransferase app-like, transcript variant X2
palmitoyltransferase app-like isoform X2
palmitoyltransferase app-like isoform X3
palmitoyltransferase app-like isoform X4
palmitoyltransferase ZDHHC18-A-like isoform X1
protein odr-4 homolog, transcript variant X2
protein odr-4 homolog, transcript variant X1
cilia- and flagella-associated protein 251-like, transcript variant X4
cilia- and flagella-associated protein 251-like, transcript variant X1
cilia- and flagella-associated protein 251-like, transcript variant X3
cilia- and flagella-associated protein 251-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cilia- and flagella-associated protein 251-like, transcript variant X2
cilia- and flagella-associated protein 251-like isoform X1
MATH and LRR domain-containing protein PFE0570w-like isoform X2
choline/ethanolamine kinase, transcript variant X4
choline/ethanolamine kinase, transcript variant X3
choline/ethanolamine kinase, transcript variant X2
choline/ethanolamine kinase, transcript variant X1
choline/ethanolamine kinase, transcript variant X5
choline/ethanolamine kinase, transcript variant X6
galactose mutarotase, transcript variant X3
galactose mutarotase, transcript variant X1
galactose mutarotase, transcript variant X2
galactose mutarotase, transcript variant X4
putative sodium-dependent multivitamin transporter, transcript variant X2
putative sodium-dependent multivitamin transporter, transcript variant X3
putative sodium-dependent multivitamin transporter, transcript variant X4
putative sodium-dependent multivitamin transporter, transcript variant X1
putative sodium-dependent multivitamin transporter isoform X1
putative sodium-dependent multivitamin transporter, transcript variant X5
putative sodium-dependent multivitamin transporter isoform X2
WD repeat-containing protein 26, transcript variant X2
WD repeat-containing protein 26, transcript variant X3
WD repeat-containing protein 26, transcript variant X4
WD repeat-containing protein 26, transcript variant X1
WD repeat-containing protein 26 isoform X1
WD repeat-containing protein 26 isoform X2
WD repeat-containing protein 26 isoform X3
tubulin-specific chaperone C, transcript variant X1
tubulin-specific chaperone C, transcript variant X3
tubulin-specific chaperone C, transcript variant X2
probable methyltransferase TARBP1, transcript variant X1
probable methyltransferase TARBP1, transcript variant X2
probable tRNA(His) guanylyltransferase, transcript variant X2
probable tRNA(His) guanylyltransferase, transcript variant X1
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X2
probable methyltransferase TARBP1 isoform X1
probable methyltransferase TARBP1 isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X5
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X4
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X4
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments
mesencephalic astrocyte-derived neurotrophic factor homolog, transcript variant X2
mesencephalic astrocyte-derived neurotrophic factor homolog, transcript variant X1
mesencephalic astrocyte-derived neurotrophic factor homolog
ubiquitin-fold modifier-conjugating enzyme 1
arginine-hydroxylase NDUFAF5, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
CDK5 regulatory subunit-associated protein 3, transcript variant X2
CDK5 regulatory subunit-associated protein 3, transcript variant X3
CDK5 regulatory subunit-associated protein 3, transcript variant X1
CDK5 regulatory subunit-associated protein 3
lateral signaling target protein 2 homolog
uncharacterized LOC124953697, transcript variant X2
uncharacterized LOC124953697, transcript variant X3
uncharacterized LOC124953697, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GATA-binding factor C-like, transcript variant X2
GATA-binding factor C-like, transcript variant X1
endothelial transcription factor GATA-2-like isoform X2
uncharacterized LOC124953696, transcript variant X1
uncharacterized LOC124953696, transcript variant X2
probable serine/threonine-protein kinase clkA
DENN domain-containing protein 10-like, transcript variant X2
DENN domain-containing protein 10-like, transcript variant X1
DENN domain-containing protein 10-like, transcript variant X3
DENN domain-containing protein 10-like, transcript variant X4
uncharacterized LOC124953689, transcript variant X3
uncharacterized LOC124953689, transcript variant X2
uncharacterized LOC124953689, transcript variant X1
uncharacterized protein LOC124953689 isoform X2
uncharacterized protein LOC124953689 isoform X1
uncharacterized LOC124953689, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC124953689 isoform X3
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X6
transcription elongation regulator 1, transcript variant X5
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X10
transcription elongation regulator 1, transcript variant X9
transcription elongation regulator 1, transcript variant X8
transcription elongation regulator 1, transcript variant X7
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X5
transcription elongation regulator 1 isoform X4
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X6
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X2
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X6
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X7
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X5
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X1
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X4
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X3
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X8
ELKS/Rab6-interacting/CAST family member 1-like, transcript variant X9
COA8 family protein CG14806, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ELKS/Rab6-interacting/CAST family member 1-like isoform X2
ELKS/Rab6-interacting/CAST family member 1-like isoform X1
ELKS/Rab6-interacting/CAST family member 1-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X3
glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X2
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X4
ubiquitin carboxyl-terminal hydrolase CYLD, transcript variant X1
ubiquitin carboxyl-terminal hydrolase CYLD isoform X2
ubiquitin carboxyl-terminal hydrolase CYLD isoform X1
nuclear pore complex protein Nup93-like, transcript variant X1
nuclear pore complex protein Nup93-like, transcript variant X3
nuclear pore complex protein Nup93-like, transcript variant X2
ADP-ribosylation factor-like protein 2-binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADP-ribosylation factor-like protein 2-binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ADP-ribosylation factor-like protein 2-binding protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ADP-ribosylation factor-like protein 2-binding protein isoform X1
ADP-ribosylation factor-like protein 2-binding protein isoform X2
ADP-ribosylation factor-like protein 2-binding protein isoform X3
protein nessun dorma, transcript variant X2
protein nessun dorma, transcript variant X1
tRNA-uridine aminocarboxypropyltransferase 1, transcript variant X1
tRNA-uridine aminocarboxypropyltransferase 1 isoform X1
tRNA-uridine aminocarboxypropyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tRNA-uridine aminocarboxypropyltransferase 1 isoform X2
uncharacterized LOC124953830, transcript variant X2
uncharacterized LOC124953830, transcript variant X1
uncharacterized LOC124953830, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124953830, transcript variant X4
uncharacterized protein LOC124953830 isoform X2
uncharacterized protein LOC124953830 isoform X3
uncharacterized protein LOC124953830 isoform X1
long-chain-fatty-acid--CoA ligase 4, transcript variant X6
long-chain-fatty-acid--CoA ligase 4, transcript variant X5
long-chain-fatty-acid--CoA ligase 4, transcript variant X3
long-chain-fatty-acid--CoA ligase 4, transcript variant X1
long-chain-fatty-acid--CoA ligase 4, transcript variant X7
long-chain-fatty-acid--CoA ligase 4, transcript variant X2
long-chain-fatty-acid--CoA ligase 4 isoform X1
long-chain-fatty-acid--CoA ligase 4, transcript variant X4
long-chain-fatty-acid--CoA ligase 4 isoform X2
long-chain-fatty-acid--CoA ligase 4 isoform X3
uncharacterized LOC124953952, transcript variant X3
uncharacterized LOC124953952, transcript variant X2
uncharacterized LOC124953952, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124953952, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124953952, transcript variant X4
uncharacterized LOC124953952, transcript variant X5
glycine-rich cell wall structural protein 1-like, transcript variant X11
glycine-rich cell wall structural protein 1-like, transcript variant X6
glycine-rich cell wall structural protein 1-like, transcript variant X9
glycine-rich cell wall structural protein 1-like, transcript variant X14
glycine-rich cell wall structural protein 1-like, transcript variant X10
glycine-rich cell wall structural protein 1-like, transcript variant X15
glycine-rich cell wall structural protein 1-like, transcript variant X7
glycine-rich cell wall structural protein 1-like, transcript variant X8
breast cancer type 1 susceptibility protein homolog
glycine-rich cell wall structural protein 1-like, transcript variant X18
glycine-rich cell wall structural protein 1-like, transcript variant X1
glycine-rich cell wall structural protein 1-like, transcript variant X2
glycine-rich cell wall structural protein 1-like, transcript variant X5
glycine-rich cell wall structural protein 1-like, transcript variant X3
glycine-rich cell wall structural protein 1-like, transcript variant X4
glycine-rich cell wall structural protein 1-like, transcript variant X17
glycine-rich cell wall structural protein 1-like, transcript variant X16
glycine-rich cell wall structural protein 1-like, transcript variant X13
glycine-rich cell wall structural protein 1-like, transcript variant X12
glycine-rich cell wall structural protein 1-like isoform X3
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative mediator of RNA polymerase II transcription subunit 26
uncharacterized LOC124953928, transcript variant X2
uncharacterized LOC124953928, transcript variant X3
uncharacterized LOC124953928, transcript variant X4
uncharacterized LOC124953928, transcript variant X1
uncharacterized LOC124953928, transcript variant X5
uncharacterized protein LOC124953928 isoform X3
uncharacterized protein LOC124953928 isoform X2
uncharacterized protein LOC124953928 isoform X1
uncharacterized protein LOC124953928 isoform X4
uncharacterized LOC124953928, transcript variant X6
uncharacterized LOC124953929, transcript variant X1
uncharacterized LOC124953929, transcript variant X2
uncharacterized LOC124953929, transcript variant X3
uncharacterized protein LOC124953929 isoform X1
uncharacterized protein LOC124953929 isoform X2
uncharacterized protein LOC124953929 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124953725, transcript variant X7
uncharacterized LOC124953725, transcript variant X5
uncharacterized LOC124953725, transcript variant X4
uncharacterized LOC124953725, transcript variant X6
uncharacterized LOC124953725, transcript variant X3
uncharacterized LOC124953725, transcript variant X1
uncharacterized LOC124953725, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inositol-pentakisphosphate 2-kinase, transcript variant X1
inositol-pentakisphosphate 2-kinase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sterol regulatory element-binding protein 1
GATOR complex protein WDR24, transcript variant X1
probable serine/threonine-protein kinase dyrk1 isoform X1
GATOR complex protein WDR24, transcript variant X2
amidophosphoribosyltransferase-like, transcript variant X2
amidophosphoribosyltransferase-like, transcript variant X1
amidophosphoribosyltransferase-like isoform X2
amidophosphoribosyltransferase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
xaa-Pro aminopeptidase 3, transcript variant X2
xaa-Pro aminopeptidase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124953721, transcript variant X3
uncharacterized protein LOC124953721 isoform X3
uncharacterized LOC124953721, transcript variant X2
uncharacterized LOC124953721, transcript variant X12
uncharacterized LOC124953721, transcript variant X8
uncharacterized LOC124953721, transcript variant X1
uncharacterized LOC124953721, transcript variant X6
uncharacterized LOC124953721, transcript variant X4
uncharacterized LOC124953721, transcript variant X5
uncharacterized protein LOC124953721 isoform X2
uncharacterized protein LOC124953721 isoform X1
uncharacterized LOC124953721, transcript variant X7
uncharacterized LOC124953721, transcript variant X9
uncharacterized LOC124953721, transcript variant X11
juvenile hormone esterase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
juvenile hormone esterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
venom carboxylesterase-6-like isoform X1
juvenile hormone esterase-like isoform X2
uncharacterized LOC124953721, transcript variant X10
pheromone-processing carboxypeptidase KEX1-like
quinone oxidoreductase-like protein 2 homolog
uncharacterized LOC124953723, transcript variant X2
uncharacterized LOC124953723, transcript variant X1
pancreatic lipase-related protein 2-like, transcript variant X1
pancreatic lipase-related protein 2-like, transcript variant X2
pancreatic lipase-related protein 2-like isoform X1
pancreatic lipase-related protein 2-like, transcript variant X3
pancreatic lipase-related protein 2-like isoform X2
pancreatic triacylglycerol lipase-like, transcript variant X5
pancreatic triacylglycerol lipase-like isoform X3
pancreatic triacylglycerol lipase-like, transcript variant X6
pancreatic triacylglycerol lipase-like, transcript variant X1
pancreatic triacylglycerol lipase-like, transcript variant X2
pancreatic triacylglycerol lipase-like, transcript variant X3
pancreatic triacylglycerol lipase-like, transcript variant X4
pancreatic triacylglycerol lipase-like isoform X4
pancreatic triacylglycerol lipase-like isoform X1
pancreatic triacylglycerol lipase-like isoform X2
uncharacterized protein DDB_G0283357, transcript variant X5
uncharacterized protein DDB_G0283357, transcript variant X4
uncharacterized protein DDB_G0283357, transcript variant X3
uncharacterized protein DDB_G0283357, transcript variant X2
uncharacterized protein DDB_G0283357, transcript variant X1
uncharacterized protein LOC124953586 isoform X3
uncharacterized protein DDB_G0283357 isoform X2
uncharacterized protein DDB_G0283357 isoform X1
ras-related protein Rab-18-B, transcript variant X2
ras-related protein Rab-18-B, transcript variant X1
uncharacterized LOC124953589, transcript variant X2
uncharacterized protein LOC124953589 isoform X2
uncharacterized LOC124953589, transcript variant X1
uncharacterized protein LOC124953589 isoform X1
protein RCC2 homolog, transcript variant X1
protein RCC2 homolog, transcript variant X4
protein RCC2 homolog, transcript variant X3
protein RCC2 homolog, transcript variant X2
translation initiation factor eIF-2B subunit gamma, transcript variant X2
translation initiation factor eIF-2B subunit gamma, transcript variant X1
translation initiation factor eIF-2B subunit gamma
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
long-chain fatty acid transport protein 4, transcript variant X7
long-chain fatty acid transport protein 4, transcript variant X5
long-chain fatty acid transport protein 4, transcript variant X1
long-chain fatty acid transport protein 4, transcript variant X2
long-chain fatty acid transport protein 4 isoform X1
long-chain fatty acid transport protein 4, transcript variant X3
long-chain fatty acid transport protein 4, transcript variant X4
long-chain fatty acid transport protein 4, transcript variant X6
long-chain fatty acid transport protein 4 isoform X2
long-chain fatty acid transport protein 4-like
transcription factor JunD-like, transcript variant X1
transcription factor JunD-like, transcript variant X2
transcription factor Jun-like isoform X1
transcription factor JunD-like isoform X2
transcription factor Jun-like, transcript variant X1
transcription factor Jun-like, transcript variant X2
transcription factor Jun-like isoform X2
mRNA (2'-O-methyladenosine-N(6)-)-methyltransferase
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X6
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X5
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X4
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X2
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X3
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X1
probable serine/threonine-protein kinase DDB_G0278845, transcript variant X7
putative uncharacterized protein DDB_G0282133 isoform X2
probable serine/threonine-protein kinase DDB_G0278845 isoform X3
uncharacterized protein DDB_G0292186-like isoform X4
probable serine/threonine-protein kinase DDB_G0278845 isoform X1
probable serine/threonine-protein kinase DDB_G0278845 isoform X5
solute carrier family 22 member 21-like, transcript variant X4
solute carrier family 22 member 21-like, transcript variant X1
solute carrier family 22 member 21-like, transcript variant X2
solute carrier family 22 member 21-like, transcript variant X3
solute carrier family 22 member 21-like, transcript variant X5
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 21-like isoform X2
solute carrier family 22 member 21-like isoform X3
tRNA modification GTPase MnmE, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tRNA modification GTPase MnmE, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tRNA modification GTPase MnmE, transcript variant X2
tRNA modification GTPase MnmE, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
tRNA modification GTPase MnmE, transcript variant X5
tRNA modification GTPase MnmE isoform X1
tRNA modification GTPase GTPBP3, mitochondrial isoform X3
tRNA modification GTPase GTPBP3, mitochondrial isoform X2
tRNA modification GTPase GTPBP3, mitochondrial isoform X4
probable cationic amino acid transporter, transcript variant X2
probable cationic amino acid transporter, transcript variant X1
probable cationic amino acid transporter, transcript variant X3
probable cationic amino acid transporter, transcript variant X4
probable cationic amino acid transporter, transcript variant X5
probable cationic amino acid transporter
solute carrier family 35 member C2, transcript variant X2
solute carrier family 35 member C2, transcript variant X3
solute carrier family 35 member C2, transcript variant X1
solute carrier family 35 member C2 isoform X2
solute carrier family 35 member C2 isoform X1
solute carrier family 35 member C2 isoform X3
E3 ubiquitin-protein ligase RNF25, transcript variant X2
E3 ubiquitin-protein ligase RNF25, transcript variant X1
protein purity of essence, transcript variant X4
protein purity of essence, transcript variant X2
protein purity of essence, transcript variant X3
protein purity of essence, transcript variant X1
golgin subfamily A member 1, transcript variant X2
golgin subfamily A member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase U, transcript variant X1
receptor-type tyrosine-protein phosphatase mu isoform X1
receptor-type tyrosine-protein phosphatase U, transcript variant X2
receptor-type tyrosine-protein phosphatase U, transcript variant X3
receptor-type tyrosine-protein phosphatase U isoform X2
H/ACA ribonucleoprotein complex non-core subunit NAF1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
riboflavin kinase, transcript variant X2
riboflavin kinase, transcript variant X1
DNA primase large subunit-like, transcript variant X2
DNA primase large subunit-like, transcript variant X1
piggyBac transposable element-derived protein 4-like, transcript variant X1
piggyBac transposable element-derived protein 4-like, transcript variant X2
piggyBac transposable element-derived protein 4-like
uncharacterized LOC124953927, transcript variant X3
uncharacterized LOC124953927, transcript variant X1
uncharacterized LOC124953927, transcript variant X2
neural/ectodermal development factor IMP-L2, transcript variant X1
neural/ectodermal development factor IMP-L2, transcript variant X2
neural/ectodermal development factor IMP-L2 isoform X1
neural/ectodermal development factor IMP-L2 isoform X2
defective pharyngeal development protein 4-like
polyadenylate-binding protein 2, transcript variant X2
polyadenylate-binding protein 2, transcript variant X1
protein zyg-11 homolog B-like, transcript variant X3
protein zyg-11 homolog B-like, transcript variant X1
protein zyg-11 homolog B-like, transcript variant X2
protein zyg-11 homolog B-like isoform X1
protein zyg-11 homolog B-like, transcript variant X4
protein zyg-11 homolog B-like isoform X2
PP2C-like domain-containing protein CG9801, transcript variant X4
PP2C-like domain-containing protein CG9801, transcript variant X3
PP2C-like domain-containing protein CG9801, transcript variant X2
PP2C-like domain-containing protein CG9801, transcript variant X1
PP2C-like domain-containing protein CG9801 isoform X1
PP2C-like domain-containing protein CG9801 isoform X3
PP2C-like domain-containing protein CG9801 isoform X2
protein PF3D7_1417600-like, transcript variant X1
protein PF3D7_1417600-like, transcript variant X2
protein PF3D7_1417600-like, transcript variant X3
uncharacterized protein LOC124953931 isoform X3
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X2
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X3
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X1
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X4
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X5
solute carrier family 2, facilitated glucose transporter member 1-like, transcript variant X6
solute carrier family 2, facilitated glucose transporter member 1-like isoform X2
solute carrier family 2, facilitated glucose transporter member 1-like isoform X3
solute carrier family 2, facilitated glucose transporter member 1-like isoform X1
solute carrier family 2, facilitated glucose transporter member 1-like isoform X4
solute carrier family 2, facilitated glucose transporter member 1-like isoform X5
solute carrier family 2, facilitated glucose transporter member 1-like isoform X6
GTP-binding protein 10 homolog, transcript variant X3
GTP-binding protein 10 homolog, transcript variant X1
GTP-binding protein 10 homolog, transcript variant X2
GTP-binding protein 10 homolog, transcript variant X4
GTP-binding protein 10 homolog isoform X1
GTP-binding protein 10 homolog isoform X2
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X5
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X3
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X4
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X2
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X6
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial, transcript variant X7
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X4
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X3
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X2
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X1
probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial isoform X5
uncharacterized LOC124953843, transcript variant X1
uncharacterized LOC124953843, transcript variant X2
uncharacterized LOC124953843, transcript variant X3
uncharacterized protein LOC124953843 isoform X1
uncharacterized protein LOC124953843 isoform X2
uncharacterized protein LOC124953843 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
10 kDa heat shock protein, mitochondrial
39S ribosomal protein L20, mitochondrial
INO80 complex subunit C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
INO80 complex subunit C, transcript variant X2
prostaglandin E synthase 3, transcript variant X2
prostaglandin E synthase 3, transcript variant X1
uncharacterized LOC124953934, transcript variant X1
uncharacterized LOC124953934, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
J domain-containing protein DDB_G0295729-like, transcript variant X5
J domain-containing protein DDB_G0295729-like, transcript variant X2
J domain-containing protein DDB_G0295729-like, transcript variant X4
J domain-containing protein DDB_G0295729-like, transcript variant X3
J domain-containing protein DDB_G0295729-like, transcript variant X1
J domain-containing protein DDB_G0295729-like isoform X2
J domain-containing protein DDB_G0295729-like isoform X4
J domain-containing protein DDB_G0295729-like isoform X3
J domain-containing protein DDB_G0295729-like isoform X1
J domain-containing protein DDB_G0295729-like isoform X5
uncharacterized LOC124953971, transcript variant X3
uncharacterized LOC124953971, transcript variant X2
uncharacterized LOC124953971, transcript variant X5
uncharacterized LOC124953971, transcript variant X4
uncharacterized LOC124953971, transcript variant X1
uncharacterized protein LOC124953971 isoform X2
uncharacterized protein LOC124953971 isoform X3
uncharacterized protein LOC124953971 isoform X1
proto-oncogene tyrosine-protein kinase receptor Ret, transcript variant X2
proto-oncogene tyrosine-protein kinase receptor Ret, transcript variant X1
proto-oncogene tyrosine-protein kinase receptor Ret isoform X2
proto-oncogene tyrosine-protein kinase receptor Ret isoform X1
synaptic vesicle glycoprotein 2B-like, transcript variant X6
synaptic vesicle glycoprotein 2B-like, transcript variant X4
synaptic vesicle glycoprotein 2B-like, transcript variant X8
synaptic vesicle glycoprotein 2B-like, transcript variant X7
synaptic vesicle glycoprotein 2B-like, transcript variant X5
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like, transcript variant X1
synaptic vesicle glycoprotein 2B-like, transcript variant X9
synaptic vesicle glycoprotein 2B-like isoform X1
synaptic vesicle glycoprotein 2B-like isoform X2
uncharacterized LOC124953677, transcript variant X1
uncharacterized LOC124953677, transcript variant X2
uncharacterized LOC124953677, transcript variant X3
outer mitochondrial transmembrane helix translocase-like, transcript variant X1
outer mitochondrial transmembrane helix translocase-like, transcript variant X2
outer mitochondrial transmembrane helix translocase-like
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X3
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X3
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X1
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X4
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN, transcript variant X5
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X4
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1
phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X5
protein bicaudal C, transcript variant X3
N6-adenosine-methyltransferase non-catalytic subunit
protein bicaudal C, transcript variant X2
protein bicaudal C, transcript variant X1
protein bicaudal C, transcript variant X4
protein bicaudal C, transcript variant X5
myeloid differentiation primary response protein MyD88-like, transcript variant X5
myeloid differentiation primary response protein MyD88-like, transcript variant X4
myeloid differentiation primary response protein MyD88-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myeloid differentiation primary response protein MyD88-like, transcript variant X3
myeloid differentiation primary response protein MyD88-like, transcript variant X1
myeloid differentiation primary response protein MyD88-like isoform X3
myeloid differentiation primary response protein MyD88-like isoform X2
myeloid differentiation primary response protein MyD88-like isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
stress-activated protein kinase JNK, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
stress-activated protein kinase JNK, transcript variant X8
stress-activated protein kinase JNK, transcript variant X7
stress-activated protein kinase JNK, transcript variant X9
stress-activated protein kinase JNK, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
stress-activated protein kinase JNK, transcript variant X10
stress-activated protein kinase JNK, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
stress-activated protein kinase JNK, transcript variant X2
stress-activated protein kinase JNK, transcript variant X3
stress-activated protein kinase JNK, transcript variant X5
stress-activated protein kinase JNK, transcript variant X12
stress-activated protein kinase JNK isoform X1
stress-activated protein kinase JNK isoform X3
stress-activated protein kinase JNK, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
stress-activated protein kinase JNK isoform X2
mitogen-activated protein kinase 1, transcript variant X6
mitogen-activated protein kinase 1, transcript variant X5
mitogen-activated protein kinase 1, transcript variant X4
mitogen-activated protein kinase 1, transcript variant X3
mitogen-activated protein kinase 1, transcript variant X2
mitogen-activated protein kinase 1, transcript variant X1
DNA-directed RNA polymerase II subunit RPB11, transcript variant X2
DNA-directed RNA polymerase II subunit RPB11, transcript variant X1
DNA-directed RNA polymerase II subunit RPB11
CAP-Gly domain-containing linker protein 1, transcript variant X2
CAP-Gly domain-containing linker protein 1, transcript variant X7
CAP-Gly domain-containing linker protein 1, transcript variant X5
CAP-Gly domain-containing linker protein 1, transcript variant X10
CAP-Gly domain-containing linker protein 1, transcript variant X4
CAP-Gly domain-containing linker protein 1, transcript variant X6
CAP-Gly domain-containing linker protein 1, transcript variant X3
CAP-Gly domain-containing linker protein 1, transcript variant X1
CAP-Gly domain-containing linker protein 1, transcript variant X8
CAP-Gly domain-containing linker protein 1, transcript variant X11
CAP-Gly domain-containing linker protein 1, transcript variant X9
CAP-Gly domain-containing linker protein 1 isoform X9
CAP-Gly domain-containing linker protein 1 isoform X10
NAD(+) hydrolase sarm1, transcript variant X2
NAD(+) hydrolase sarm1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
NAD(+) hydrolase sarm1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NAD(+) hydrolase sarm1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
NAD(+) hydrolase sarm1, transcript variant X1
NAD(+) hydrolase sarm1, transcript variant X7
NAD(+) hydrolase sarm1, transcript variant X6
NAD(+) hydrolase sarm1, transcript variant X5
serine/threonine-protein kinase NLK, transcript variant X1
serine/threonine-protein kinase NLK, transcript variant X2
ubiquitin-protein ligase E3B, transcript variant X3
ubiquitin-protein ligase E3B, transcript variant X2
ubiquitin-protein ligase E3B, transcript variant X1
E3 ubiquitin-protein ligase RNF185-like, transcript variant X3
E3 ubiquitin-protein ligase RNF185-like, transcript variant X2
E3 ubiquitin-protein ligase RNF185-like, transcript variant X4
E3 ubiquitin-protein ligase RNF185-like, transcript variant X1
dynein axonemal intermediate chain 4-like
heat shock protein DDB_G0288861, transcript variant X4
heat shock protein DDB_G0288861, transcript variant X5
heat shock protein DDB_G0288861, transcript variant X6
heat shock protein DDB_G0288861, transcript variant X1
heat shock protein DDB_G0288861, transcript variant X2
heat shock protein DDB_G0288861, transcript variant X3
uncharacterized protein LOC124953955 isoform X1
uncharacterized protein LOC124953955 isoform X2
heat shock protein DDB_G0288861 isoform X3
uncharacterized protein LOC124953955 isoform X4
heat shock protein DDB_G0288861, transcript variant X7
uncharacterized protein LOC124953955 isoform X5
transmembrane protein 138, transcript variant X2
transmembrane protein 138, transcript variant X1
transmembrane protein 138, transcript variant X4
transmembrane protein 138, transcript variant X3
myotubularin-related protein 2, transcript variant X3
myotubularin-related protein 2, transcript variant X1
myotubularin-related protein 2, transcript variant X5
myotubularin-related protein 2, transcript variant X7
myotubularin-related protein 2, transcript variant X4
myotubularin-related protein 2, transcript variant X6
myotubularin-related protein 2, transcript variant X2
myotubularin-related protein 2 isoform X1
myotubularin-related protein 2 isoform X2
myotubularin-related protein 2 isoform X3
myotubularin-related protein 2 isoform X4
myotubularin-related protein 2 isoform X5
nose resistant to fluoxetine protein 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nose resistant to fluoxetine protein 6-like, transcript variant X1
nose resistant to fluoxetine protein 6-like isoform X2
nose resistant to fluoxetine protein 6-like isoform X1
uncharacterized LOC124953748, transcript variant X3
uncharacterized LOC124953748, transcript variant X2
uncharacterized LOC124953748, transcript variant X1
26S proteasome non-ATPase regulatory subunit 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
26S proteasome non-ATPase regulatory subunit 5, transcript variant X1
26S proteasome non-ATPase regulatory subunit 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 29% coverage of the annotated genomic feature by RNAseq alignments
T-cell immunomodulatory protein, transcript variant X1
T-cell immunomodulatory protein, transcript variant X2
putative inorganic phosphate cotransporter, transcript variant X3
putative inorganic phosphate cotransporter, transcript variant X2
putative inorganic phosphate cotransporter, transcript variant X1
putative inorganic phosphate cotransporter isoform X2
putative inorganic phosphate cotransporter isoform X1
putative inorganic phosphate cotransporter isoform X3
glutamate receptor ionotropic, delta-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 188 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, delta-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 184 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, delta-1-like isoform X1
glutamate receptor ionotropic, delta-1-like isoform X2
BMP-binding endothelial regulator protein, transcript variant X2
BMP-binding endothelial regulator protein, transcript variant X3
BMP-binding endothelial regulator protein, transcript variant X6
BMP-binding endothelial regulator protein, transcript variant X4
BMP-binding endothelial regulator protein, transcript variant X1
BMP-binding endothelial regulator protein, transcript variant X8
BMP-binding endothelial regulator protein, transcript variant X5
BMP-binding endothelial regulator protein, transcript variant X9
BMP-binding endothelial regulator protein, transcript variant X7
BMP-binding endothelial regulator protein
NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X1
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X6
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X5
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X4
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X2
RNA pseudouridylate synthase domain-containing protein 2-like, transcript variant X3
RNA pseudouridylate synthase domain-containing protein 2-like isoform X1
RNA pseudouridylate synthase domain-containing protein 2-like isoform X2
nuclear pore complex protein Nup214-like, transcript variant X1
nuclear pore complex protein Nup214-like, transcript variant X2
nuclear pore complex protein Nup214-like
14 kDa phosphohistidine phosphatase-like, transcript variant X1
14 kDa phosphohistidine phosphatase-like, transcript variant X2
14 kDa phosphohistidine phosphatase-like isoform X2
14 kDa phosphohistidine phosphatase-like isoform X1
phosrestin-2-like, transcript variant X3
phosrestin-2-like, transcript variant X1
phosrestin-2-like, transcript variant X2
mitochondrial mRNA pseudouridine synthase Trub2
high affinity copper uptake protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
high affinity copper uptake protein 1, transcript variant X1
high affinity copper uptake protein 1 isoform X2
high affinity copper uptake protein 1 isoform X1
LOW QUALITY PROTEIN: nucleolar protein 58-like
ecdysone-induced protein 74EF-like, transcript variant X1
ecdysone-induced protein 74EF-like, transcript variant X2
spectrin alpha chain, transcript variant X1
spectrin alpha chain, transcript variant X2
RNA-splicing ligase RtcB homolog, transcript variant X1
RNA-splicing ligase RtcB homolog isoform X1
RNA-splicing ligase RtcB homolog, transcript variant X2
RNA-splicing ligase RtcB homolog isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC124953611
pescadillo homolog, transcript variant X2
pescadillo homolog, transcript variant X1
translation initiation factor eIF-2B subunit alpha, transcript variant X1
translation initiation factor eIF-2B subunit alpha, transcript variant X2
translation initiation factor eIF-2B subunit alpha isoform X1
translation initiation factor eIF-2B subunit alpha isoform X2
tyrosine-protein kinase Fer, transcript variant X3
tyrosine-protein kinase Fer, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tyrosine-protein kinase Fer, transcript variant X1
tyrosine-protein kinase Fer, transcript variant X2
phosphopantothenate--cysteine ligase, transcript variant X2
phosphopantothenate--cysteine ligase, transcript variant X1
vacuolar protein sorting-associated protein 16 homolog, transcript variant X3
vacuolar protein sorting-associated protein 16 homolog, transcript variant X1
vacuolar protein sorting-associated protein 16 homolog, transcript variant X2
vacuolar protein sorting-associated protein 16 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124953631, transcript variant X2
uncharacterized LOC124953631, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC124953631, transcript variant X3
uncharacterized protein LOC124953631 isoform X1
uncharacterized protein LOC124953631 isoform X2
uncharacterized protein LOC124953631 isoform X3
bone morphogenetic protein 1, transcript variant X4
bone morphogenetic protein 1, transcript variant X6
bone morphogenetic protein 1, transcript variant X3
bone morphogenetic protein 1, transcript variant X5
bone morphogenetic protein 1, transcript variant X2
bone morphogenetic protein 1, transcript variant X7
bone morphogenetic protein 1, transcript variant X1
dorsal-ventral patterning tolloid-like protein 1 isoform X2
bone morphogenetic protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bone morphogenetic protein 1, transcript variant X10
bone morphogenetic protein 1, transcript variant X9
heterogeneous nuclear ribonucleoprotein R, transcript variant X6
heterogeneous nuclear ribonucleoprotein R, transcript variant X11
heterogeneous nuclear ribonucleoprotein R, transcript variant X9
heterogeneous nuclear ribonucleoprotein R, transcript variant X10
heterogeneous nuclear ribonucleoprotein R, transcript variant X19
heterogeneous nuclear ribonucleoprotein R, transcript variant X2
heterogeneous nuclear ribonucleoprotein R, transcript variant X7
heterogeneous nuclear ribonucleoprotein R, transcript variant X5
heterogeneous nuclear ribonucleoprotein R, transcript variant X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X12
heterogeneous nuclear ribonucleoprotein R, transcript variant X3
heterogeneous nuclear ribonucleoprotein R, transcript variant X4
heterogeneous nuclear ribonucleoprotein R, transcript variant X8
heterogeneous nuclear ribonucleoprotein R isoform X2
heterogeneous nuclear ribonucleoprotein R isoform X10
heterogeneous nuclear ribonucleoprotein R isoform X6
heterogeneous nuclear ribonucleoprotein R isoform X5
heterogeneous nuclear ribonucleoprotein R isoform X4
heterogeneous nuclear ribonucleoprotein R isoform X3
heterogeneous nuclear ribonucleoprotein R isoform X1
heterogeneous nuclear ribonucleoprotein R, transcript variant X17
heterogeneous nuclear ribonucleoprotein R, transcript variant X14
heterogeneous nuclear ribonucleoprotein R, transcript variant X16
heterogeneous nuclear ribonucleoprotein R, transcript variant X15
heterogeneous nuclear ribonucleoprotein R isoform X9
heterogeneous nuclear ribonucleoprotein R isoform X7
heterogeneous nuclear ribonucleoprotein R isoform X8
heterogeneous nuclear ribonucleoprotein R, transcript variant X13
heterogeneous nuclear ribonucleoprotein R, transcript variant X18
mitochondrial pyruvate carrier 1-like, transcript variant X2
mitochondrial pyruvate carrier 1-like, transcript variant X1
mitochondrial pyruvate carrier 1-like isoform X2
mitochondrial pyruvate carrier 1-like isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC124953706
serine/threonine-protein kinase Warts-like
venom protease-like, transcript variant X1
venom protease-like, transcript variant X2
venom protease-like, transcript variant X4
venom protease-like, transcript variant X3
MAGUK p55 subfamily member 7, transcript variant X1
MAGUK p55 subfamily member 7, transcript variant X2
MAGUK p55 subfamily member 7, transcript variant X3
MAGUK p55 subfamily member 7, transcript variant X4
protein bric-a-brac 1-like, transcript variant X2
protein bric-a-brac 1-like, transcript variant X1
uncharacterized LOC124953799, transcript variant X1
uncharacterized LOC124953799, transcript variant X2
uncharacterized LOC124953799, transcript variant X3
uncharacterized protein LOC124953799 isoform X2
uncharacterized protein LOC124953799 isoform X1
uncharacterized protein LOC124953799 isoform X3
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 1 isoform X1
ubiquitin carboxyl-terminal hydrolase 1 isoform X2
ubiquitin carboxyl-terminal hydrolase 1, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 1 isoform X3
uridine phosphorylase 1, transcript variant X3
uridine phosphorylase 1, transcript variant X1
uridine phosphorylase 1, transcript variant X2
uncharacterized LOC124953795, transcript variant X9
uncharacterized LOC124953795, transcript variant X7
uncharacterized LOC124953795, transcript variant X8
uncharacterized LOC124953795, transcript variant X10
uncharacterized LOC124953795, transcript variant X5
uncharacterized LOC124953795, transcript variant X4
uncharacterized LOC124953795, transcript variant X2
uncharacterized LOC124953795, transcript variant X3
uncharacterized LOC124953795, transcript variant X1
uncharacterized protein LOC124953795 isoform X1
uncharacterized protein LOC124953795 isoform X2
uncharacterized protein LOC124953795 isoform X3
uncharacterized protein LOC124953795 isoform X4
uncharacterized LOC124953795, transcript variant X6
uncharacterized protein LOC124953795 isoform X5
ecdysone 20-monooxygenase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X4
ecdysone 20-monooxygenase, transcript variant X7
ecdysone 20-monooxygenase, transcript variant X6
ecdysone 20-monooxygenase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X13
ecdysone 20-monooxygenase, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X2
ecdysone 20-monooxygenase, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ecdysone 20-monooxygenase, transcript variant X12
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X2
uncharacterized aarF domain-containing protein kinase 2-like, transcript variant X1
uncharacterized aarF domain-containing protein kinase 2-like isoform X1
uncharacterized aarF domain-containing protein kinase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
adenosine 3'-phospho 5'-phosphosulfate transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3, transcript variant X2
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X3
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X1
DNA-directed RNA polymerases I, II, and III subunit RPABC3 isoform X2
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X2
phosphatidate cytidylyltransferase, photoreceptor-specific, transcript variant X1
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X2
phosphatidate cytidylyltransferase, photoreceptor-specific isoform X1
kinesin light chain, transcript variant X10
kinesin light chain, transcript variant X8
kinesin light chain, transcript variant X7
kinesin light chain, transcript variant X6
kinesin light chain, transcript variant X9
kinesin light chain, transcript variant X13
kinesin light chain, transcript variant X2
kinesin light chain, transcript variant X4
kinesin light chain, transcript variant X1
kinesin light chain, transcript variant X3
kinesin light chain, transcript variant X11
kinesin light chain, transcript variant X5
kinesin light chain, transcript variant X12
eukaryotic translation initiation factor 5
uncharacterized LOC124953668, transcript variant X1
uncharacterized LOC124953668, transcript variant X2
uncharacterized protein LOC124953668 isoform X1
uncharacterized protein LOC124953668 isoform X2
arylalkylamine N-acetyltransferase 1-like, transcript variant X1
arylalkylamine N-acetyltransferase 1-like
arylalkylamine N-acetyltransferase 1-like, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X2
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X1
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like, transcript variant X3
lipopolysaccharide-induced tumor necrosis factor-alpha factor-like
acetylcholine receptor subunit alpha-L1, transcript variant X3
acetylcholine receptor subunit alpha-L1, transcript variant X2
acetylcholine receptor subunit alpha-L1, transcript variant X1
acetylcholine receptor subunit alpha-L1 isoform X2
acetylcholine receptor subunit alpha-L1 isoform X1
acetylcholine receptor subunit alpha-like 1, transcript variant X1
acetylcholine receptor subunit alpha-like 1, transcript variant X4
acetylcholine receptor subunit alpha-like 1, transcript variant X3
acetylcholine receptor subunit alpha-like 1, transcript variant X2
acetylcholine receptor subunit alpha-like 1 isoform X1
acetylcholine receptor subunit alpha-like 1 isoform X2
uncharacterized LOC124953590, transcript variant X2
uncharacterized LOC124953590, transcript variant X3
uncharacterized protein LOC124953590 isoform X2
uncharacterized LOC124953590, transcript variant X4
uncharacterized LOC124953590, transcript variant X1
uncharacterized LOC124953590, transcript variant X5
uncharacterized protein LOC124953590 isoform X1
uncharacterized protein LOC124953590 isoform X3
uncharacterized LOC124953596, transcript variant X2
uncharacterized LOC124953596, transcript variant X1
uncharacterized LOC124953613, transcript variant X1
uncharacterized protein LOC124953613 isoform X1
uncharacterized LOC124953613, transcript variant X2
uncharacterized protein LOC124953613 isoform X2
uncharacterized LOC124953606, transcript variant X4
uncharacterized LOC124953606, transcript variant X2
uncharacterized LOC124953606, transcript variant X3
uncharacterized LOC124953606, transcript variant X1
uncharacterized LOC124953606, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124953577, transcript variant X1
uncharacterized LOC124953577, transcript variant X3
uncharacterized LOC124953577, transcript variant X2
uncharacterized LOC124953682, transcript variant X4
uncharacterized LOC124953682, transcript variant X3
uncharacterized LOC124953682, transcript variant X1
uncharacterized LOC124953682, transcript variant X2
uncharacterized LOC124953682, transcript variant X6
uncharacterized LOC124953682, transcript variant X7
uncharacterized LOC124953682, transcript variant X5
mitochondrial folate transporter/carrier
mitochondrial ribonuclease P catalytic subunit
protein sprint-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
protein sprint-like, transcript variant X6
protein sprint-like, transcript variant X5
protein sprint-like, transcript variant X4
protein sprint-like, transcript variant X2
protein sprint-like, transcript variant X3
protein sprint-like, transcript variant X7
protein sprint-like, transcript variant X8
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
uncharacterized LOC124953686, transcript variant X2
uncharacterized LOC124953686, transcript variant X1
odorant receptor 13a-like, transcript variant X2
odorant receptor 13a-like, transcript variant X1